Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 26, 2019
[The Foundation of Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Clinical Laboratory Tests in This Field]Mika Nakamae
Cureus|December 6, 2023
A Case of IgG1-Lambda Multiple Myeloma With Hyperviscosity Syndrome and Cryoglobulinemia: Identification of the Subclass Fraction by Immunoelectrophoresis and Immunofixation ElectrophoresisKumiyo Tazoe, Naonori Harada, Kazuya Takemura, et al.
International Journal of Hematology|November 17, 2021
Predictive value of clinical examination parameters for cardiovascular adverse events during treatment of chronic myeloid leukemia with tyrosine kinase inhibitorsMika Nakamae, Hirohisa Nakamae, Mika Hashimoto, et al.
American Journal of Hematology|June 7, 2006
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantationHirohisa Nakamae, Takahisa Yamane, Taro Hasegawa, et al.
International Journal of Hematology|March 29, 2026
Phase-specific impact of hypogammaglobulinemia on bacterial infections after allogeneic hematopoietic cell transplantationHidekatsu Yae, Mitsutaka Nishimoto, Hiroshi Okamura, et al.
Cancer|October 26, 2005
Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisoloneHirohisa Nakamae, Kei Tsumura, Yoshiki Terada, et al.
Transplantation|May 16, 2017
Autonomic Nervous System Pretransplant Malfunction Is a Powerful Predictor of Survival After Allogeneic Hematopoietic Cell TransplantationTakahiko Nakane, Mika Nakamae, Hideo Koh, et al.
Acta Haematologica|December 5, 2014
Prognostic value and clinical implication of serum ferritin levels following allogeneic hematopoietic cell transplantationMika Nakamae, Hirohisa Nakamae, Shiro Koh, et al.
Cancer Science|April 20, 2022
Immunomodulatory and direct activities of ropeginterferon alfa-2b on cancer cells in mouse models of leukemiaKazuki Sakatoku, Yasuhiro Nakashima, Joji Nagasaki, et al.
Experimental Hematology|January 14, 2015
Response-guided therapy for steroid-refractory acute GVHD starting with very-low-dose antithymocyte globulinMitsutaka Nishimoto, Hirohisa Nakamae, Hideo Koh, et al.
Pageof 9